Experimental Drugs News
Most Popular Experimental Drugs Story
Lilly readies Phase III Alzheimer's trial
Struggling to right itself after a long dry spell in new drug approvals, Eli Lilly is preparing to a launch a late-stage study of an experimental drug for Alzheimer's. LY450139 is expected to inhibit... Read more...
Latest Headlines
- March 31, 2008
- March 27, 2008
- January 9, 2008
- November 26, 2007
- September 27, 2007
- September 7, 2007
- August 8, 2007
- July 5, 2007
- January 9, 2007
- December 18, 2006
- December 11, 2006
- December 7, 2006
- November 12, 2006
- November 9, 2006
- August 6, 2006
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
